BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34197342)

  • 1. Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance.
    Kaji I; Roland JT; Rathan-Kumar S; Engevik AC; Burman A; Goldstein AE; Watanabe M; Goldenring JR
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34197342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease.
    Kaji I; Roland JT; Watanabe M; Engevik AC; Goldstein AE; Hodges CA; Goldenring JR
    Gastroenterology; 2020 Oct; 159(4):1390-1405.e20. PubMed ID: 32534933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MYO5B Leads to Reductions in Na
    Engevik AC; Kaji I; Engevik MA; Meyer AR; Weis VG; Goldstein A; Hess MW; Müller T; Koepsell H; Dudeja PK; Tyska M; Huber LA; Shub MD; Ameen N; Goldenring JR
    Gastroenterology; 2018 Dec; 155(6):1883-1897.e10. PubMed ID: 30144427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.
    Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level.
    Bowman DM; Kaji I; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2022; 14(3):553-565. PubMed ID: 35660026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of intestinal ion transport defects in microvillus inclusion disease.
    Kravtsov DV; Ahsan MK; Kumari V; van Ijzendoorn SC; Reyes-Mugica M; Kumar A; Gujral T; Dudeja PK; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G142-55. PubMed ID: 27229121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
    Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
    Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
    Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease.
    Szperl AM; Golachowska MR; Bruinenberg M; Prekeris R; Thunnissen AM; Karrenbeld A; Dijkstra G; Hoekstra D; Mercer D; Ksiazyk J; Wijmenga C; Wapenaar MC; Rings EH; van IJzendoorn SC
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):307-13. PubMed ID: 21206382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
    Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
    J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
    van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
    Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.
    Thoeni CE; Vogel GF; Tancevski I; Geley S; Lechner S; Pfaller K; Hess MW; Müller T; Janecke AR; Avitzur Y; Muise A; Cutz E; Huber LA
    Traffic; 2014 Jan; 15(1):22-42. PubMed ID: 24138727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
    Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease.
    Michaux G; Massey-Harroche D; Nicolle O; Rabant M; Brousse N; Goulet O; Le Bivic A; Ruemmele FM
    Biol Cell; 2016 Jan; 108(1):19-28. PubMed ID: 26526116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of syntaxin 3 causes variant microvillus inclusion disease.
    Wiegerinck CL; Janecke AR; Schneeberger K; Vogel GF; van Haaften-Visser DY; Escher JC; Adam R; Thöni CE; Pfaller K; Jordan AJ; Weis CA; Nijman IJ; Monroe GR; van Hasselt PM; Cutz E; Klumperman J; Clevers H; Nieuwenhuis EE; Houwen RH; van Haaften G; Hess MW; Huber LA; Stapelbroek JM; Müller T; Middendorp S
    Gastroenterology; 2014 Jul; 147(1):65-68.e10. PubMed ID: 24726755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease.
    Schlegel C; Weis VG; Knowles BC; Lapierre LA; Martin MG; Dickman P; Goldenring JR; Shub MD
    Dig Dis Sci; 2018 Feb; 63(2):356-365. PubMed ID: 29218485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myo5b knockout mice as a model of microvillus inclusion disease.
    Cartón-García F; Overeem AW; Nieto R; Bazzocco S; Dopeso H; Macaya I; Bilic J; Landolfi S; Hernandez-Losa J; Schwartz S; Ramon y Cajal S; van Ijzendoorn SC; Arango D
    Sci Rep; 2015 Jul; 5():12312. PubMed ID: 26201991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects.
    Forteza R; Ahsan MK; Cartón-García F; Arango D; Ameen NA; Salas PJ
    Mol Biol Cell; 2019 Dec; 30(26):3076-3089. PubMed ID: 31664880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
    Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
    Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.